Abstract
When allograft failure or severe dysfunction of an orthotopically or heterotopically transplanted heart occurs, replacement of the heart may be indicated and can substantially extend patient survival. There are surprisingly few reported data on the indications for retransplantation, or on the complications and results of this procedure[1]’[4].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Copeland JG, Griepp RB, Bieber CP et al. Successful retransplantation of the human heart. J Thorac Cardiovasc Surg. 1977;73:242.
Baumgartner WA, Reitz BA, Oyer PH., Stinson KB, Shumway NH. Cardiac homotransplantation. Curr Probl Surg. 1979;16:1.
Copeland JG, Slinson EB. Human heart transplantation. Curr Prubl Cardiol. 1979;4:4.
Watson DC, Reitz, BA, Oyer Ph, Stinson KB, Shumway NE. Sequential orthotopic heart transplantation in man. Transplantation. 1980;30:401.
Novitzky D, Cooper DKC, Barnard CN. Orthotopic heart transplantation in a patient with a heterotopic heart transplant. Heart Transplant. 1984;3:257.
Wahlers T, Frimpong-Boateng K, Haverich A et al. Management of immediate graft failure after cardiac transplantation using cardiopulmonary bypass and intra-aortic balloon-pumping followed by cardiac retransplantation. Thorac Cardiovasc Surg. 1986;34:389.
Morris JS, Lower RR, Szentpetery S. Immediate graft failure treated with partial cardiopulmonary bypass and emergency cardiac retransplantation. Transplant Proc. 1987;19:2497.
Jurmann MJ, Wahlers T, Coppola R, Fieguth H-G, Haverich A. Early graft failure after heart transplantation: management by extracorporeal circulatory assist and retransplantation. J Heart Transplant. 1989;8:474.
Mullins P, Chauhan A, Aravot D et al. Acute heart retransplantation. Lancet. 1991;337:1552.
Collins KG, Mozdzierz GJ. Cardiac re-transplantation: determining limits. Heart Lung. 1993;22:206.
Evans RW. A cost-outcome analysis of relransplantation: the need for accountability. Transplant Rev. 1993;7:163.
Lanza RP, Campbell E, Cooper DKC, Du Toit E, Barnard CN. The problem of the presensitized heart transplant recipient. Heart Transplant. 1983;2:151.
Ensley RD, Hunt S, Taylor DO et al. Predictors of survival after repeat heart transplantation. J Heart Lung Transplant. 1992:11:S142.
Cooper DKC, Charles RP, Fraser RC, Beck W, Barnard CN. Long-term survival after orthotopic and heterotopic cardiac transplantation. Br Med J. 1980;281:1093.
Rose AG, UYS CJ, Cooper DKC, Barnard CN. Donor heart morphology 12 1/2 years after orthotopic transplantation. Heart Transplant. 1982;1:329.
Royston D. Aprotinin therapy in heart and heart-lung transplantation. J Heart Lung Transplant. 1993;12:S19.
Propst JW, Siegel LC, Keeley TW. Effect of aprotinin on transfusion requirements during repeal sternotomy for cardiac transplantation surgery. Transplant Proc. 1994;26:3719.
Michler RH, McLaughlin MJ, Chen JM et al. Clinical experience with cardiac reransplantation. J Thorac Cardiovasc Surg. 1993;106:622.
Karwande SV, Ensley RD, Renlund DG et al. Cardiac retransplantation: a viable option? Ann Thorac Surg. 1992;54:840.
Dein JR, Oyer PK, Stinson EB, Starnes VA, Shumway NE. Cardiac retransplantation in the cyclosporin era. Ann Thorac Surg. 1989;48:350.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Taniguchi, S., Cooper, D.K.C. (1996). Cardiac Retransplantation - Indications and Results. In: Cooper, D.K.C., Miller, L.W., Patterson, G.A. (eds) The Transplantation and Replacement of Thoracic Organs. Springer, Dordrecht. https://doi.org/10.1007/978-0-585-34287-0_36
Download citation
DOI: https://doi.org/10.1007/978-0-585-34287-0_36
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-8898-2
Online ISBN: 978-0-585-34287-0
eBook Packages: Springer Book Archive